Vir Biotechnology (VIR) Q2 2026 Earnings

May 6Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-1.17
-0.81
-0.45
-0.1

Details

Expected EPS
-0.0955
Actual EPS
-0.85
Surprise EPS
-0.75
Surprise Percent
-790.05%

Description

⁨Vir Biotechnology⁩ (⁦VIR⁩) has reported earnings of ⁦-0.85⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts